[ad_1] A view of Google Headquarters in Mountain View, California, United States on April 16, 2024. …
Tag: Eli Lilly and Co
How digital health companies are capitalizing on the GLP-1 boom
[ad_1] Patent protection for Wegovy — Novo Nordisk’s blockbuster weight loss drug, which contains the second…
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York…
This up-and-coming cancer treatment could be a $25 billion market opportunity — it’s already a hotbed for M&A
[ad_1] Skynesher | E+ | Getty Images Big pharma is betting billions on an up-and-coming class…
A corner of the cancer therapy market is heating up—Here are the names investors need to know
[ad_1] There’s been a lot of attention lately on a corner of the oncology market called…
AstraZeneca targets $80 billion in total revenue by 2030 in ‘post-Covid era’
[ad_1] The Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai, China,…
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York…
Wegovy maker Novo Nordisk extends losses following first-quarter results
[ad_1] Shares of Danish pharmaceutical giant Novo Nordisk slid 2.5% on Friday, extending a 2.7% loss on Thursday…
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
[ad_1] Pavlo Gonchar | Lightrocket | Getty Images Amgen‘s stock rose more than 12% on Friday…
Amgen scraps experimental weight loss pill, moves forward with injection
[ad_1] The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17,…
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
[ad_1] A food delivery messenger carries a take out bag outside aSweetgreen in Manhattan on September…
Promise of Eli Lilly’s weight-loss drug for sleep apnea adds another reason to own the stock
[ad_1] Eli Lilly ‘s weight-loss drug Zepbound showed promise as a treatment for sleep apnea —…
Eli Lilly’s weight loss drug Zepbound shows promise as a sleep apnea treatment in late-stage trials
[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York…
Most doses of Eli Lilly’s Zepbound, Mounjaro in short supply through June, FDA says
[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York…